Elevage Medical Technologies

Elevage Medical Technologies operates as a specialized investment firm focused on empowering the medical device sector. The company provides strategic capital and operational expertise to medical technology companies, enabling them to advance innovative solutions for patient care. Its approach centers on identifying and nurturing enterprises with the potential to significantly improve health outcomes and enhance patients' quality of life.

Elevage Medical Technologies was formed in May 2023 by Patient Square Capital, a dedicated health care investment firm. This initiative was born from the insight that a focused platform could optimally support medical device innovation. Patient Square Capital appointed Evan Melrose as CEO to lead this dedicated effort, leveraging his extensive experience in the healthcare investment landscape.

The firm's core clientele comprises early to growth-stage medical device companies seeking more than just capital; they seek a partner with deep industry knowledge. Elevage Medical Technologies aims to accelerate the development and commercialization of next-generation medical technologies, ultimately driving better health outcomes and extending quality of life for patients globally through its portfolio companies.